Treatment with Nucala, an interleukin-5 antagonist monoclonal antibody, significantly reduced exacerbations leading to hospitalizations and emergency department visits. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback